{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:55Z","timestamp":1791478375157,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2023\/2024"],"award-info":[{"award-number":["2023\/2024"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.htct.2026.106470","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:17:03Z","timestamp":1778933823000},"page":"106470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5052-7906","authenticated-orcid":false,"given":"Estela Gasparotto","family":"Emiliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-7943","authenticated-orcid":false,"given":"Gustavo Emmanuel Alves Abrantes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7177-7664","authenticated-orcid":false,"given":"Eliana Cristina Martins","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-2654","authenticated-orcid":false,"given":"Gislaine Borba Oliveira","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6058-7558","authenticated-orcid":false,"given":"Guilherme Brasil Duffles","family":"Amarante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-8374","authenticated-orcid":false,"given":"Carmino Ant\u00f4nio","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-0805","authenticated-orcid":false,"given":"Katia Borgia Barbosa","family":"Pagnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106470_bib0001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5045\/br.2022.2021173","article-title":"Chronic myeloid leukemia: a type of MPN","volume":"57","author":"Samad","year":"2022","journal-title":"Blood Res"},{"key":"10.1016\/j.htct.2026.106470_bib0002","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/sj.leu.2401565","article-title":"Chronic myeloid leukemia from basics to bedside","volume":"13","author":"Thijsen","year":"1999","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.htct.2026.106470_bib0003","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1590\/s1679-45082011rb2022","article-title":"Chronic myeloid leukemia: past, present, future","volume":"9","author":"Bollmann","year":"2011","journal-title":"Einstein (S\u00e3o Paulo)"},{"issue":"48","key":"10.1016\/j.htct.2026.106470_bib0004","first-page":"1","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin J Cancer"},{"issue":"2","key":"10.1016\/j.htct.2026.106470_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am J Hematol"},{"issue":"24","key":"10.1016\/j.htct.2026.106470_bib0006","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3390\/ijms20246141","article-title":"Mechanisms of disease progression and resistance to Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update","volume":"20","author":"Bavaro","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.htct.2026.106470_bib0007","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.htct.2026.106470_bib0008","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.23.01689","article-title":"CML and the WHO: why?","volume":"42","author":"Berman","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.htct.2026.106470_bib0009","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2026.106470_bib0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.htct.2026.106470_bib0011","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.htct.2026.106470_bib0012","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.htct.2026.106470_bib0013","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.htct.2026.106470_bib0014","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/hematology.2023000446","article-title":"Accelerated-phase CML: de novo and transformed","volume":"2023","author":"Shanmuganathan","year":"2023","journal-title":"Hematol Am Soc Hematol. Educ Progr"},{"issue":"1","key":"10.1016\/j.htct.2026.106470_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/leu.2015.261","article-title":"Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia","volume":"30","author":"Pfirrmann","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.htct.2026.106470_bib0016","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.htct.2026.106470_bib0017","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3390\/cells12131703","article-title":"Prognosis in chronic myeloid leukemia: baseline factors, dynamic risk assessment and novel insights","volume":"12","author":"Iezza","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.htct.2026.106470_bib0018","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ajh.27007","article-title":"Classification of accelerated phase chronic myeloid leukemia in the era of the BCR::ABL1 tyrosine kinase inhibitors: a work in progress","volume":"98","author":"Kantarjian","year":"2023","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.htct.2026.106470_bib0019","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.27229","article-title":"De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors","volume":"99","author":"Hornak","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.htct.2026.106470_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41375-024-02486-2","article-title":"Is there really an accelerated phase of chronic myeloid leukaemia at presentation?","volume":"39","author":"Yang","year":"2025","journal-title":"Leukemia"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:48Z","timestamp":1791475488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2531137926002178"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106470","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106470"}}